SS Innovations International to Present SSi Mantra Surgical Robot at Society of Robotic Surgery Annual Meeting

SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.

Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries, while approximately 2,100 physicians have been trained on the platform.

The presentation at the Society of Robotic Surgery Annual Meeting underscores the growing importance of telesurgery and the global expansion of robotic surgical technologies. SS Innovations aims to make robotic surgery more affordable and accessible, which could have significant implications for healthcare delivery in underserved regions. The live telesurgery demonstration highlights the potential for remote surgical expertise to reach patients in distant locations, reducing the need for travel and enabling timely interventions.

For more details, the full press release is available at https://ibn.fm/YYYKE. SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. The company’s product range includes the SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures, including cardiac surgery.

As an American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The company’s forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, involve risks and uncertainties that could cause actual results to differ materially. Detailed risk factors are discussed in the company's filings with the SEC, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.